LENZ Therapeutics, Inc.

General ticker "LENZ" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $722.0M (TTM average)

LENZ Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -24.0%.

Estimated limits based on current volatility of 2.4%: low 6.36$, high 6.78$

Factors to consider:

  • Total employees count: 69 as of 2021
  • Current price 32.8% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [9.43$, 22.17$]
  • 2026-12-31 to 2027-12-31 estimated range: [7.32$, 17.38$]

Financial Metrics affecting the LENZ estimates:

  • Negative: with PPE of -6.0 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Industry operating income (median)
  • Negative: Industry earnings per price (median), % of -13.66 <= 0

Similar symbols

Short-term LENZ quotes

Long-term LENZ plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $19.09MM
Operating Expenses $72.43MM $58.61MM $110.23MM
Operating Income $-72.43MM $-58.61MM $-91.14MM
Non-Operating Income $2.28MM $8.84MM $9.51MM
R&D Expense $59.50MM $29.80MM $18.67MM
Income(Loss) $-70.15MM $-49.77MM $-81.62MM
Taxes $-0.18MM $0.00MM $0.50MM
Net Income(Loss)* $-69.97MM $-49.77MM $-82.13MM
Stockholders Equity $183.58MM $204.08MM $284.34MM
Assets $188.46MM $215.30MM $305.88MM
Operating Cash Flow $-60.38MM $-59.39MM $-69.17MM
Capital expenditure $0.03MM $0.47MM $0.83MM
Investing Cash Flow $-29.62MM $-154.48MM $-75.67MM
Financing Cash Flow $80.70MM $199.00MM $149.75MM
Earnings Per Share** $-8.59 $-2.34 $-2.85

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.